econometric models

Summary

Summary: The application of mathematical formulas and statistical techniques to the testing and quantifying of economic theories and the solution of economic problems.

Top Publications

  1. ncbi Equity in health care utilization: further tests based on hurdle models and Swedish micro data
    U G Gerdtham
    Centre for Health Economics, Stockholm School of Economics, Sweden
    Health Econ 6:303-19. 1997
  2. ncbi The Medicaid Rx model: pharmacy-based risk adjustment for public programs
    T Gilmer
    Department of Family and Preventive Medicine, University of California, San Diego 92093 0622, USA
    Med Care 39:1188-202. 2001
  3. ncbi Social capital, life expectancy and mortality: a cross-national examination
    Brendan Kennelly
    Department of Economics, The National University of Ireland, Galway, Ireland
    Soc Sci Med 56:2367-77. 2003
  4. ncbi The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique
    Ulla K Griffiths
    Department of Vaccines and Biologicals, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
    Health Policy Plan 20:50-9. 2005
  5. ncbi Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States
    Colin W Shepard
    Division of Viral Hepatitis, National Center for Infectious Diseases, US Centers for Disease Control and Prevention, 1600 Clifton Rd, MS G37, Atlanta, GA 30333, USA
    Pediatrics 115:1220-32. 2005
  6. ncbi Estimating log models: to transform or not to transform?
    W G Manning
    Department of Health Studies, Harris School of Public Policy Studies, The University of Chicago, IL 60637, USA
    J Health Econ 20:461-94. 2001
  7. ncbi An analysis of private health insurance purchasing decisions with national health insurance in Taiwan
    Tsai Ching Liu
    Department ol Puhlie Finance, National Taipei University, Taiwan
    Soc Sci Med 55:755-74. 2002
  8. ncbi Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures
    Melinda Beeuwkes Buntin
    RAND Health, Washington Office, 1200 South Hayes Street, Arlington, VA 22202 5050, USA
    J Health Econ 23:525-42. 2004
  9. ncbi The estimation of a preference-based measure of health from the SF-36
    John Brazier
    Sheffield Health Economics Group, School of Health and Related Research, University of Sheffield, UK
    J Health Econ 21:271-92. 2002
  10. pmc Use of econometric models to estimate expenditure shares
    Justin G Trogdon
    RTI International, 3040 Cornwallis Rd, PO Box 12194, Research Triangle Park, NC 27709 2194, USA
    Health Serv Res 43:1442-52. 2008

Detail Information

Publications239 found, 100 shown here

  1. ncbi Equity in health care utilization: further tests based on hurdle models and Swedish micro data
    U G Gerdtham
    Centre for Health Economics, Stockholm School of Economics, Sweden
    Health Econ 6:303-19. 1997
    ..g. income and size of community of residence. Size of community of residence has a positive significant effect on the frequency of physician visits but not on the probability of visiting a physician...
  2. ncbi The Medicaid Rx model: pharmacy-based risk adjustment for public programs
    T Gilmer
    Department of Family and Preventive Medicine, University of California, San Diego 92093 0622, USA
    Med Care 39:1188-202. 2001
    ..Here, we explore the use of pharmacy data as an alternative or complement to diagnostic data in risk adjustment...
  3. ncbi Social capital, life expectancy and mortality: a cross-national examination
    Brendan Kennelly
    Department of Economics, The National University of Ireland, Galway, Ireland
    Soc Sci Med 56:2367-77. 2003
    ..The paper casts doubt upon the widely accepted hypothesis that social capital has a positive effect on health and illustrates the importance of testing this kind of hypothesis in an extended model...
  4. ncbi The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique
    Ulla K Griffiths
    Department of Vaccines and Biologicals, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
    Health Policy Plan 20:50-9. 2005
    ..To estimate the cost-effectiveness of introducing hepatitis B vaccine into routine infant immunization services in Mozambique, which took place in the year 2001...
  5. ncbi Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States
    Colin W Shepard
    Division of Viral Hepatitis, National Center for Infectious Diseases, US Centers for Disease Control and Prevention, 1600 Clifton Rd, MS G37, Atlanta, GA 30333, USA
    Pediatrics 115:1220-32. 2005
    ..The US Food and Drug Administration approved a meningococcal conjugate A/C/Y/W-135 vaccine (MCV-4) for use in persons aged 11 to 55 years in January, 2005; licensure for use in younger age groups is expected in 2 to 4 years...
  6. ncbi Estimating log models: to transform or not to transform?
    W G Manning
    Department of Health Studies, Harris School of Public Policy Studies, The University of Chicago, IL 60637, USA
    J Health Econ 20:461-94. 2001
    ..The paper provides a straightforward algorithm for choosing among the alternative estimators. Even if the estimators considered are consistent, there can be major losses in precision from selecting a less appropriate estimator...
  7. ncbi An analysis of private health insurance purchasing decisions with national health insurance in Taiwan
    Tsai Ching Liu
    Department ol Puhlie Finance, National Taipei University, Taiwan
    Soc Sci Med 55:755-74. 2002
    ..In addition, one important implication in the private health insurance market is highlighted. There is no complementarity between the public and private systems...
  8. ncbi Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures
    Melinda Beeuwkes Buntin
    RAND Health, Washington Office, 1200 South Hayes Street, Arlington, VA 22202 5050, USA
    J Health Econ 23:525-42. 2004
    ..It finds that four of the alternatives produce very similar results in practice. It then suggests an efficient method for researchers to use when selecting estimators of health care costs...
  9. ncbi The estimation of a preference-based measure of health from the SF-36
    John Brazier
    Sheffield Health Economics Group, School of Health and Related Research, University of Sheffield, UK
    J Health Econ 21:271-92. 2002
    ..These problems must be weighed against the rich descriptive ability of the SF-6D, and the potential application of these models to existing and future SF-36 data set...
  10. pmc Use of econometric models to estimate expenditure shares
    Justin G Trogdon
    RTI International, 3040 Cornwallis Rd, PO Box 12194, Research Triangle Park, NC 27709 2194, USA
    Health Serv Res 43:1442-52. 2008
    ..To investigate the use of regression models to calculate disease-specific shares of medical expenditures...
  11. ncbi Risk adjustment in Switzerland
    Konstantin Beck
    Department of Statistics, PO Box 2568, CH 6002, Lucerne, Switzerland
    Health Policy 65:63-74. 2003
    ..The paper concludes with a description of the current political and scientific discussion in Switzerland...
  12. ncbi Accounting for the cost of scaling-up health interventions
    Benjamin Johns
    Global Programme on Evidence for Health Policy GPE EQC, World Health Organization, CH 1211 Geneva 27, Switzerland
    Health Econ 13:1117-24. 2004
    ..Results show changing marginal costs as predicted by economic theory...
  13. ncbi Estimating marginal and incremental effects on health outcomes using flexible link and variance function models
    Anirban Basu
    Section of General Internal Medicine, Department of Medicine, University of Chicago, 5841 South Maryland Ave MC 2007, Chicago IL 60637, USA
    Biostatistics 6:93-109. 2005
    ..Using Monte Carlo simulations, we show that the resulting parameter estimators are consistent. The method is illustrated with an analysis of inpatient expenditure data from a study of hospitalists...
  14. pmc Cost-effectiveness of male circumcision for HIV prevention in a South African setting
    James G Kahn
    Institute for Health Policy Studies, University of California San Francisco, San Francisco, California, United States of America
    PLoS Med 3:e517. 2006
    ..The objective of this study is to present the first cost-effectiveness analysis of the use of MC as an intervention to reduce the spread of HIV in sub-Saharan Africa...
  15. ncbi Willingness to pay for improved respiratory and cardiovascular health: a multiple-format, stated-preference approach
    F R Johnson
    Triangle Economic Research, Durham 27713, USA
    Health Econ 9:295-317. 2000
    ..Thus, using generic health attributes facilitates transferring WTP estimates for benefit-cost analysis of a variety of potential health interventions...
  16. ncbi Cost-effectiveness of a trial of labor after previous cesarean
    A Chung
    Department of Anesthesia and Gynecology and Obstetrics, Stanford University School of Medicine, Stanford, California 94305-5640, USA
    Obstet Gynecol 97:932-41. 2001
    ..74. Improved algorithms are needed to more precisely estimate the likelihood that a patient with a previous cesarean will have a successful vaginal delivery...
  17. pmc Applying diagnosis and pharmacy-based risk models to predict pharmacy use in Aragon, Spain: the impact of a local calibration
    Amaia Calderón-Larrañaga
    Aragon Health Science Institute, 25, Gomez Laguna Ave, Zaragoza 50009, Spain
    BMC Health Serv Res 10:22. 2010
    ..Developed primarily for the U.S. health care setting, a secondary objective was to evaluate the benefit of a local calibration in order to adapt the PMs to the Spanish health care system...
  18. pmc Principal inpatient diagnostic cost group model for Medicare risk adjustment
    G C Pope
    Health Economics Research, Inc, Waltham, MA 02452, USA
    Health Care Financ Rev 21:93-118. 2000
    ..In this article, the authors describe the risk-adjustment model HCFA is implementing in the year 2000, known as the Principal Inpatient Diagnostic Cost Group (PIPDCG) model...
  19. ncbi A multilevel modelling approach to analysis of patient costs under managed care
    K Carey
    Management Science Group, US Department of Veterans Affairs, Bedford, MA, USA
    Health Econ 9:435-46. 2000
    ..Facilities more heavily penetrated by the managed care model may be more effective at controlling costs of their sicker patients...
  20. ncbi Much ado about two: reconsidering retransformation and the two-part model in health econometrics
    J Mullahy
    University of Wisconsin Madison 53706, USA
    J Health Econ 17:247-81. 1998
    ....
  21. ncbi Medical care use and selection in a social health insurance with an equalization fund: evidence from Colombia
    Antonio J Trujillo
    College of Health and Public Affairs, University of Central Florida, USA
    Health Econ 12:231-46. 2003
    ..On the other hand, the evidence on selection is somewhat mixed: individuals who report good health status are more likely to participate in SHIEF, while those without a chronic condition are less likely to participate in SHIEF...
  22. ncbi Estimating inequalities in ownership of insecticide treated nets: does the choice of socio-economic status measure matter?
    Jane Chuma
    Kenya Medical Research Institute, Kilifi, Kenya
    Health Policy Plan 24:83-93. 2009
    ..In the meantime, careful selection of SES measure is required for every study, depending on the health policy issue of interest, the research context and, inevitably, pragmatic considerations...
  23. ncbi Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease
    Erik J Dasbach
    Merck Research Laboratories, Blue Bell, PA, USA
    Epidemiol Rev 28:88-100. 2006
    ....
  24. ncbi Is cigarette smoking in poorer nations highly sensitive to price? Evidence from Russia and China
    Peter M Lance
    Department of Economics, 107 Gardner Hall, CB 3305, University of North Carolina, Chapel Hill, NC 27599 3305, USA
    J Health Econ 23:173-89. 2004
    ..In contrast, our micro-level price elasticity estimates in China and Russia range from 0 to -0.15. Thus, raising prices in poorer countries may not reduce smoking to the degree previously suggested...
  25. ncbi Repeated tobacco-use screening and intervention in clinical practice: health impact and cost effectiveness
    Leif I Solberg
    HealthPartners Research Foundation, Bloomington, Minnesota 55425, USA
    Am J Prev Med 31:62-71. 2006
    ..It also addresses repeated counseling because the literature has focused on single episodes of treatment, while in reality that is neither desirable nor likely...
  26. ncbi The effect of variable health insurance deductibles on the demand for physician visits
    M Schellhorn
    Institute of Economics, University of Bern, Switzerland
    Health Econ 10:441-56. 2001
    ....
  27. ncbi The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda
    Elliot Marseille
    Health Strategies International, Orinda, California 94563, USA
    AIDS 20:907-14. 2006
    ..The objective of this study was to determine the financial incentives that companies have to treat HIV-infected employees, in a health care services company in Kampala, Uganda...
  28. ncbi Will a global subsidy of new antimalarials delay the emergence of resistance and save lives?
    Ramanan Laxminarayan
    Resources for the Future in Washington, DC, USA
    Health Aff (Millwood) 25:325-36. 2006
    ..We find that even a partial subsidy could delay the emergence of resistance and that a delay in implementing a subsidy for ACTs could facilitate the emergence of resistance and lower the economic value of ACTs...
  29. pmc Finding future high-cost cases: comparing prior cost versus diagnosis-based methods
    A S Ash
    Department of General Internal Medicine, Boston University, MA 02118, USA
    Health Serv Res 36:194-206. 2001
    ..Combined cost and diagnostic data are even more powerful and more operation ally useful, especially because the diagnostic information identifies the medical problems that may be managed to achieve better out comes and lower costs...
  30. ncbi Predicting costs of care using a pharmacy-based measure risk adjustment in a veteran population
    Anne E Sales
    VA Puget Sound Health Care System, Seattle, Washington 98108, USA
    Med Care 41:753-60. 2003
    ..The Veterans Health Administration (VHA) is an ideal environment in which to test the efficacy of a pharmacy-based approach...
  31. pmc Measuring population health risks using inpatient diagnoses and outpatient pharmacy data
    Y Zhao
    DxCG Inc, Boston, MA 02111, USA
    Health Serv Res 36:180-93. 2001
    ..Properly organized and in combination these data are promising predictors of future costs...
  32. ncbi Catastrophe and impoverishment in paying for health care: with applications to Vietnam 1993-1998
    Adam Wagstaff
    The World Bank, Washington, DC 20433, USA
    Health Econ 12:921-34. 2003
    ....
  33. ncbi Predicting pharmacy costs and other medical costs using diagnoses and drug claims
    Yang Zhao
    DxCG, Inc, Boston, Massachusetts, USA
    Med Care 43:34-43. 2005
    ..Predicting health care costs for individuals and populations is essential for managing care. However, the comparative power of diagnostic and drug data for predicting future costs has not been closely examined...
  34. ncbi Measuring the impact of health insurance with a correction for selection bias--a case study of Ecuador
    H R Waters
    CRS Peru, Baltimore, MD 21201, USA
    Health Econ 8:473-83. 1999
    ..The Seguro Campesino Social (SSC) programme, directed at farming populations, has positive but insignificant associations with both curative and preventive care...
  35. ncbi The impact of tobacco control program expenditures on aggregate cigarette sales: 1981-2000
    Matthew C Farrelly
    RTI, 3040 Cornwallis Road, Research Triangle Park, NC 27709, USA
    J Health Econ 22:843-59. 2003
    ..Our analyses clearly show that increases in funding for state tobacco control programs reduce tobacco use...
  36. pmc A clinically detailed risk information system for cost
    G M Carter
    RAND, Santa Monica, CA 90407 2138, USA
    Health Care Financ Rev 21:65-91. 2000
    ..A prospective model with additional payments for birth episodes and for serious problems in newborns would be an effective risk adjuster for Medicaid programs...
  37. ncbi The compensating income variation of cardiovascular disease
    Wim Groot
    Faculty of Health Sciences, Department of H O P E, Maastricht University, Maastricht, The Netherlands
    Health Econ 15:1143-8. 2006
    ..It is found that the CIV decreases with age and is higher for men than for women. For women the estimated CIV is similar to those calculated by Groot et al. (2004). For men the estimates are somewhat higher than earlier reported...
  38. pmc The health plan choices of retirees under managed competition
    T C Buchmueller
    Graduate School of Management, University of California, Irvine 92697, USA
    Health Serv Res 35:949-76. 2000
    ..To investigate the effect of price on the health insurance decisions of Medicare-eligible retirees in a managed competition setting...
  39. ncbi Exploring the costs of a limited public sector antiretroviral treatment programme in South Africa
    Andrew Boulle
    School of Public Health and Primary Health Care, University of Cape Town
    S Afr Med J 92:811-7. 2002
    ..This study seeks to explore the impact of these programme choices at an individual level, as well as explore the total cost of a rationed national public sector antiretroviral treatment programme...
  40. ncbi Estimates of use and costs of behavioural health care: a comparison of standard and finite mixture models
    P Deb
    Department of Economics, Indiana University Purdue University Indianapolis, IN 46202, USA
    Health Econ 9:475-89. 2000
    ..The empirical advantages of the FMM translate into superior estimates of mean costs and utilization that have widespread application in rate-setting exercises...
  41. ncbi Risk adjustment using automated ambulatory pharmacy data: the RxRisk model
    Paul A Fishman
    Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA
    Med Care 41:84-99. 2003
    ..Each model's power to forecast health care resource use is assessed...
  42. ncbi Cost function estimation: the choice of a model to apply to dementia
    C K Andersen
    Institute of Public Health, Health Economics, University of Southern Denmark, Odense, Denmark
    Health Econ 9:397-409. 2000
    ..For the two-part model, the estimated health care costs ranged from DKK 44714, for a very mildly demented patient, to DKK 197 840, for a severely demented patient...
  43. ncbi Predictive modeling of total healthcare costs using pharmacy claims data: a comparison of alternative econometric cost modeling techniques
    Christopher A Powers
    Caremark, Hunt Valley, MD 21031, USA
    Med Care 43:1065-72. 2005
    ....
  44. ncbi Deductibles and health care expenditures: empirical estimates of price sensitivity based on administrative data
    René C J A van Vliet
    Institute of Health Policy and Management iBMG, Erasmus University Rotterdam, P O Box 1738, 3000 DR Rotterdam, The Netherlands
    Int J Health Care Finance Econ 4:283-305. 2004
    ..To estimate the price sensitivity of demand for health care by analysing the relation between deductibles and expenditures found in an administrative database...
  45. ncbi A model of the impact of reimbursement schemes on health plan choice
    E B Keeler
    Harvard University, Cambridge, MA 02138, USA
    J Health Econ 17:297-320. 1998
    ..Severity adjustment and to a lesser extent reduced supply-side cost-sharing improve market performance, but outcomes are efficient only in cases in which people bear the marginal costs of their choices...
  46. ncbi Switching costs, price sensitivity and health plan choice
    Bruce A Strombom
    Analysis Group Economics Inc, Los Angelus, CA 90017, USA
    J Health Econ 21:89-116. 2002
    ..Simulations combining our results with actuarial data illustrate the cost implications of risk-related differences in price elasticity...
  47. ncbi Money for health: the equivalent variation of cardiovascular diseases
    Wim Groot
    Department of Economics, University of Amsterdam, The Netherlands
    Health Econ 13:859-72. 2004
    ..The cost-benefit analysis shows that for most interventions the value of the health benefits exceeds the costs. Heart transplants seem to be too costly and only beneficial if patients are young...
  48. ncbi Smoking-attributable medical care costs in the USA
    V P Miller
    Berkeley Economic Research Associates, CA 94705, USA
    Soc Sci Med 48:375-91. 1999
    ..Results for the fifty states are presented. Conclusions and subjects for further research are discussed...
  49. ncbi Duplicate coverage and demand for health care. The case of Catalonia
    A M Vera-Hernández
    Department of Economics and Economic History, Universitat Autonoma de Barcelona, Barcelona, Spain
    Health Econ 8:579-98. 1999
    ..b>Econometric models, estimated by the generalized method of moments, accommodate both the endogeneity of insurance choice ..
  50. ncbi Hospital efficiency targets
    Rowena Jacobs
    Centre for Health Economics, University of York, UK
    Health Econ 12:669-84. 2003
    ..A pressing need for future work is the development of measures to encourage efficiency that take account of quality improvement...
  51. ncbi Latent class versus two-part models in the demand for physician services across the European Union
    Sergi Jiménez-Martín
    Department of Economics, Universidad Carlos III de Madrid, Spain
    Health Econ 11:301-21. 2002
    ..The results suggest that latent class models are more appropriate than two-part models to estimate general practitioners utilisation while the opposite is found for visits to the specialists...
  52. ncbi Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument
    Kevin L Sloan
    VA Puget Sound Health Care System, Seattle, Washington 98108, USA
    Med Care 41:761-74. 2003
    ..Our goal was to provide a reliable and valid pharmacy-based case-mix classification system for chronic diseases found in the Veterans Health Administration (VHA) population...
  53. ncbi Latent class models for utilisation of health care
    Teresa Bago d'Uva
    Centre for Health Economics, University of York, UK
    Health Econ 15:329-43. 2006
    ....
  54. ncbi Cost efficiency of US hospitals: a stochastic frontier approach
    M D Rosko
    School of Business Administration, Widener University, Chester, PA 19013, USA
    Health Econ 10:539-51. 2001
    ..Inefficiency was negatively associated with health maintenance organization (HMO) penetration and industry concentration. It was positively related with Medicare share and for-profit ownership status...
  55. pmc Endogeneity in logistic regression models
    George Avery
    Emerg Infect Dis 11:503-4; author reply 504-5. 2005
  56. ncbi Technological development and medical productivity: the diffusion of angioplasty in New York state
    David M Cutler
    T17 Morgan Hall, Harvard Business School, Boston, MA 02163, USA
    J Health Econ 22:187-217. 2003
    ..PTCAs that substitute for CABG cost less and have the same or better outcomes, while PTCAs that replace medical management appear to improve health by enough to justify the cost...
  57. ncbi Parametric modelling of cost data in medical studies
    R M Nixon
    Biostatistics Unit, University Forvie Site MRC, Robinson Way, Cambridge CB2 2SR, U K
    Stat Med 23:1311-31. 2004
    ..Investigating the sensitivity of conclusions to choice of model should thus be an essential component of analysing cost data in practice...
  58. ncbi Technical efficiency in the use of health care resources: a comparison of OECD countries
    Donna Retzlaff-Roberts
    Management Science, University of South Alabama, Mobile, AL, USA
    Health Policy 69:55-72. 2004
    ..Specifically, we find that the USA can substantially reduce inputs while maintaining the current level of life expectancy...
  59. ncbi A time-tradeoff method for cost-effectiveness models applied to radiology
    J S Swan
    Department of Radiology, Indiana University, Indianapolis 46202, USA
    Med Decis Making 20:79-88. 2000
    ..This method was tested by assessing patients' preferences for magnetic resonance angiography (MRA) versus x-ray angiography (XRA)...
  60. ncbi Assessment of health economics in Alzheimer's disease (AHEAD): treatment with galantamine in the UK
    A Ward
    Caro Research Institute, Concord, MA 01742, USA
    Int J Geriatr Psychiatry 18:740-7. 2003
    ..To assess the long-term health and economic impact of treating mild to moderate Alzheimer's disease (AD) with galantamine (16 mg or 24 mg per day) compared to no cholinesterase therapy in the UK...
  61. ncbi Assessment of Health Economics in Alzheimer's Disease (AHEAD): treatment with galantamine in Sweden
    Frances B Garfield
    Caro Research Institute, Concord, Massachusetts 01742, USA
    Pharmacoeconomics 20:629-37. 2002
    ..Galantamine, a new acetylcholinesterase inhibitor and nicotinic modulator, has proved effective in managing patients with Alzheimer's disease in clinical trials...
  62. ncbi The cost utility analysis of riluzole for the treatment of amyotrophic lateral sclerosis in the UK
    M Tavakoli
    Department of Management, University of St Andrews, St Katharine s West, The Scores, Fife, KY16 9AL Scotland, St Andrews, UK
    J Neurol Sci 191:95-102. 2001
    ....
  63. pmc HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries
    Elliot Marseille
    Institute of Health Policy Studies, University of California, San Francisco, USA
    BMC Health Serv Res 7:108. 2007
    ..Information on the relationship between scale and unit costs is critical to project the cost of global HIV prevention efforts and to allocate prevention resources efficiently...
  64. ncbi Indirect costs and cost-effectiveness analysis
    Richard Ernst
    Value Health 9:253-61. 2006
    ....
  65. pmc Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial
    G Kobelt
    European Health Economics SAS, 492 chemin des Laurens, F 06530 Spéracèdes, France
    Ann Rheum Dis 64:1174-9. 2005
    ....
  66. ncbi Using contrast sensitivity to estimate the cost-effectiveness of verteporfin in patients with predominantly classic age-related macular degeneration
    N Bansback
    Health Economics and Decision Science, ScHARR School of Health and Related Research, University of Sheffield, Sheffield, UK
    Eye (Lond) 21:1455-63. 2007
    ....
  67. pmc An economic evaluation of prolonged mechanical ventilation
    Christopher E Cox
    Division of Pulmonary and Critical Care Medicine, Department of Medicine, Duke University, Durham, NC, USA
    Crit Care Med 35:1918-27. 2007
    ..Therefore, we aimed to determine the lifetime societal value of prolonged mechanical ventilation...
  68. ncbi Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke
    Lars Ehlers
    HTA Unit, Aarhus University Hospital, Olof Palmes Allé 17, 8200 Aarhus N, Denmark
    Stroke 38:85-9. 2007
    ..The aim of this study was to assess the costs and cost-effectiveness of intravenous thrombolysis treatment with alteplase (Actilyse) of acute ischemic stroke with 24-hour in-house neurology coverage and use of magnetic resonance imaging...
  69. ncbi Cost-effectiveness of antiplatelet agents in secondary stroke prevention: the limits of certainty
    David B Matchar
    Center for Clinical Health Policy Research, Duke University, Durham, NC 27705, USA
    Value Health 8:572-80. 2005
    ..Which of the available antiplatelet therapies should be preferred for secondary prevention of recurrent ischemic stroke has been contentious...
  70. ncbi Cost effectiveness of adult intensive care in the UK
    S Ridley
    Glan Clwyd Hospital, Rhyl, Denbighshire LL18 5UJ, UK
    Anaesthesia 62:547-54. 2007
    ..Despite the high daily cost of intensive care, its cost-effectiveness is excellent and compares favourably with other commonly used health interventions. Our findings suggest that adult intensive care represents good value for money...
  71. ncbi Cost-effectiveness analysis of a quality-controlled mammography screening program from the Swiss statutory health-care perspective: quantitative assessment of the most influential factors
    Kurt Neeser
    Swiss Institute for Medical Decision Support SIMEDES, Muttenz, Switzerland
    Value Health 10:42-53. 2007
    ..The purpose of this economic analysis was to assess the cost-effectiveness of MSP compared with an established opportunistic screening strategy (OS) in Switzerland, to identify the major factors influencing the economic outcome...
  72. ncbi Global cost-effectiveness of cataract surgery
    Van C Lansingh
    Fundacion Vision, Asuncion, Paraguay
    Ophthalmology 114:1670-8. 2007
    ..To determine the cost-effectiveness of cataract surgery worldwide and to compare it with the cost-effectiveness of comparable medical interventions...
  73. ncbi Cost-effectiveness of four immunomodulatory therapies for relapsing-remitting multiple sclerosis: a Markov model based on long-term clinical data
    Christopher Bell
    Health Economics, USA
    J Manag Care Pharm 13:245-61. 2007
    ....
  74. ncbi Impact of triage in accident and emergency departments in Bahrain
    B E Fateha
    Office of Medical Review, Ministry of Health, Manama, Bahrain
    East Mediterr Health J 7:812-8. 2001
    ..3% and 17.3%. We conclude that triage by physicians can be cost-effective and can reduce the AE Department workload, freeing more time to manage life-threatening and urgent cases...
  75. ncbi Pertussis immunization of adolescents in the United States: an economic evaluation
    J Jaime Caro
    Caro Research Institute, Concord, MA 01742, USA
    Pediatr Infect Dis J 24:S75-82. 2005
    ..Although there is considerable uncertainty surrounding key inputs, the results indicate that the conditions required for adolescent immunization to be economically warranted are realistic...
  76. pmc The value of health
    Wim Groot
    BMC Health Serv Res 8:136. 2008
    ..Lacking a notion about the value of a QALY, all ultimate values to the cost-effectiveness ratio are essentially arbitrary...
  77. ncbi Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study
    Talitha L Feenstra
    National Institute of Public Health and the Environment, Bilthoven, The Netherlands
    Value Health 8:178-90. 2005
    ....
  78. ncbi The burden of illness associated with renal cell carcinoma in the United States
    Kathleen Lang
    i3 Innovus, Medford, MA 02155, USA
    Urol Oncol 25:368-75. 2007
    ..Available treatments for localized RCC frequently lead to cure; however RCC patients with advanced disease have limited treatment options and low survival rates. Data on the economic burden of RCC are limited...
  79. ncbi Cost-effectiveness of aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with highly emetogenic chemotherapy
    Susan Moore
    Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA
    Value Health 10:23-31. 2007
    ..Nevertheless, the cost-effectiveness of standard aprepitant use has not been established...
  80. pmc The cost-effectiveness of early noninvasive ventilation for ALS patients
    Kirsten L Gruis
    Department of Neurology, University of Michigan Health System, Ann Arbor, Michigan, USA
    BMC Health Serv Res 5:58. 2005
    ..We therefore used a cost-utility analysis to determine a priori what magnitude of health-related quality of life (HRQL) improvement early NIPPV initiation would need to achieve to be cost-effective in a future clinical trial...
  81. ncbi Potential costs and benefits of newborn screening for severe combined immunodeficiency
    Sean A McGhee
    Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, 90095 1752, USA
    J Pediatr 147:603-8. 2005
    ..SCID is a candidate for universal newborn screening, so there is a need to determine under which circumstances screening would be cost-effective...
  82. ncbi Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003
    Kristian Bolin
    Department of Economics, Lund University, Sweden
    Respir Med 102:699-710. 2008
    ..To calculate incremental cost-utility ratios (cost per QALY gained) for varenicline (Champix; Pfizer), as compared to bupropion, in smoking-cessation programmes for a lifetime follow-up period...
  83. pmc Cost, affordability and cost-effectiveness of strategies to control tuberculosis in countries with high HIV prevalence
    Christine S M Currie
    School of Mathematics, University of Southampton, Southampton, SO17 1BJ, UK
    BMC Public Health 5:130. 2005
    ..However, published cost and cost-effectiveness studies are limited...
  84. ncbi A value-based medicine cost-utility analysis of idiopathic epiretinal membrane surgery
    Omesh P Gupta
    Retina Service, Wills Eye Institute, Philadelphia, Pennsylvania 19107, USA
    Am J Ophthalmol 145:923-8. 2008
    ..To perform a reference case, cost-utility analysis of epiretinal membrane (ERM) surgery using current literature on outcomes and complications...
  85. ncbi Cost-effectiveness analysis of rituximab combined with chop for treatment of diffuse large B-cell lymphoma
    Jennie H Best
    Department of Pharmacy, University of Washington, Seattle, WA 98195, USA
    Value Health 8:462-70. 2005
    ....
  86. ncbi Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetes
    Andrew J Palmer
    CORE Center for Outcomes Research, Binningen Basel, Switzerland
    Curr Med Res Opin 20:S41-51. 2004
    ....
  87. ncbi Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate
    M Vera-Llonch
    Policy Analysis Inc, Brookline, MA 02445, USA
    Rheumatology (Oxford) 47:535-41. 2008
    ..To assess cost-effectiveness of abatacept in patients with moderately to severely active RA and inadequate response to MTX...
  88. ncbi Cost-effectiveness of a community-level HIV risk reduction intervention for women living in low-income housing developments
    Ana P Johnson-Masotti
    Medical College of Wisconsin, USA
    J Prim Prev 26:345-62. 2005
    ..This paper represents an example of how an analysis of cost-effectiveness can provide policymakers with information needed for difficult decisions about prevention resource allocations...
  89. pmc Option appraisal of population-based colorectal cancer screening programmes in England
    Paul Tappenden
    School of Health and Related Research, The University of Sheffield, Regent Court, 30 Regent Street, Sheffield S1 4DA, UK
    Gut 56:677-84. 2007
    ....
  90. pmc Cost effectiveness of interferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C
    R Grieve
    Health Services Research Unit, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK
    Gut 55:1332-8. 2006
    ..For patients with mild chronic hepatitis C the cost effectiveness of antiviral therapy is unknown...
  91. ncbi Valuing prevention: discounting health benefits and costs in New Zealand
    Richard Milne
    Section of Epidemiology and Biostatistics, School of Population Health, University of Auckland, Auckland, New Zealand
    N Z Med J 118:U1443. 2005
  92. ncbi Deleterious effects of increased body weight associated with intensive insulin therapy for type 1 diabetes: increased blood pressure and worsened lipid profile partially negate improvements in life expectancy
    Andrew J Palmer
    CORE Center for Outcomes Research, Binningen Basel, Switzerland
    Curr Med Res Opin 20:S67-73. 2004
    ....
  93. ncbi The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making
    Andrew J Palmer
    CORE Center for Outcomes Research, Basel, Switzerland
    Curr Med Res Opin 20:S5-26. 2004
    ..The development of complications, life expectancy, quality-adjusted life expectancy and total costs within populations can be calculated...
  94. ncbi Efficient use of health care resources: the interaction between improved health and reduced health related income loss
    Michael Hoel
    Department of Economics, University of Oslo, P O Box 1095, N 0317 Oslo, Norway
    Int J Health Care Finance Econ 2:285-96. 2002
    ..Net marginal costs are equal to gross marginal costs minus the reduction in health related income losses due to treatment. In the general case where marginal utilities depend on the health state this rule must be modified...
  95. ncbi Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States
    Joseph A Caprini
    Evanston Northwestern Healthcare, Evanston, IL, USA
    Value Health 6:59-74. 2003
    ..Estimates of the cost of long-term complications of a primary deep vein thrombosis (DVT), including the post-thrombotic syndrome (PTS) and recurrent venous thromboembolism (VTE), may be relevant for resource allocation decisions...
  96. ncbi Willingness to pay methods in health care: a sceptical view
    Richard Cookson
    Health Econ 12:891-4. 2003
  97. ncbi A clinical decision and economic analysis model of cancer pain management
    Amy P Abernethy
    Center for Clinical Health Policy Research, Department of Medicine, Duke University Medical Center, 2200 W Main St, Suite 230, Durham, NC 27705, USA
    Am J Manag Care 9:651-64. 2003
    ....
  98. ncbi State AIDS Drug Assistance Programs: equity and efficiency in an era of rapidly changing treatment standards
    Mira Johri
    Department of Health Administration, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada
    Med Care 40:429-41. 2002
    ..The 54 state AIDS Drug Assistance Programs (ADAP) provide medications to HIV-infected persons with limited resources. Eligibility and coverage vary, raising concerns about health inequities...
  99. ncbi The benefits of switching smoking cessation drugs to over-the-counter status
    Theodore E Keeler
    Department of Economics, University of California, Berkeley 94720 3880, USA
    Health Econ 11:389-402. 2002
    ..8-2 billion dollars, based on conservative estimates both of the number of quits achieved and the value of added quality-adjusted life years from the reduced smoking...
  100. ncbi Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosis
    J Jaime Caro
    Caro Research Institute, Concord, Massachusetts 01742, USA
    Pharmacoeconomics 20:593-602. 2002
    ....
  101. ncbi Appraising the economic efficiency of cancer treatment: an exploratory analysis of lung cancer
    Thomas N Chirikos
    H Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Cancer Control, MRC, 12902 Magnolia Drive, Tampa, FL 33612 9497, USA
    Health Care Manag Sci 6:87-95. 2003
    ..These findings imply that the delivery of lung cancer care is inefficient. Substantive and methodological implications are discussed...

Research Grants64

  1. IMPACT OF MGD CARE ON DEMAND FOR PREVENTIVE & CURATIVE M
    PRAVIN TRIVEDI; Fiscal Year: 2002
    ..Our econometric models will involve two sets of jointly dependent variables: an equation to explain enrollment in HMO or other ..
  2. Drug Coverage and Cost Offsets: Two-Part Models with Endogenous Treatment Effects
    JOSEPH TERZA; Fiscal Year: 2009
    ....
  3. EHR-Based Clinical Decision Support to Improve BP Management in Adolescents
    ELYSE OLSHEN-KHARBANDA; Fiscal Year: 2013
    ..in outpatient care costs will be offset by longer-term clinical benefits, estimated using established econometric models. This innovative project (a) addresses the under-recognized high-risk patient population of adolescents, (b) ..
  4. Health Care Financing over the Life Cycle:A Quantitative Macroeconomic Analysis o
    JUERGEN JUNG; Fiscal Year: 2010
    ..However, current research in health economics which relies mainly on microeconomic and econometric models falls short in providing a framework suitable for analyzing macroeconomic consequences of health care ..
  5. Innovative methods for modeling longitudianl medical costs
    Lei Liu; Fiscal Year: 2013
    ..There are five aims in this grant. First, we will expand the currently available econometric models of medical costs to longitudinal data and compare the performance of these models...
  6. A web hospital comparison tool for patients considering kidney transplantation an
    Constantia Petrou; Fiscal Year: 2010
    ..tool that will address gaps that exist in current hospital ranking systems using advanced statistical and econometric models that have never been applied in this space. In phase 1 we developed Pickcare v2...
  7. Economic Analysis of the Impact of Food Advertisements
    John Cawley; Fiscal Year: 2007
    ..Our specific aims are to estimate two-part econometric models of the impact of advertisements on: 1) youths' visits to specific fast food establishments, and youth ..
  8. HEALTH STATUS AND FAMILY SUPPORT OF THE ELDERLY
    ROBERT SCHOENI; Fiscal Year: 2001
    ..behavior, Paul Gertler is a Senior Health Economist at RAND who has extensive experience with behavioral and econometric models of health status...
  9. Irish Fertility at the Turn of the Twentieth Century
    TIMOTHY GUINNANE; Fiscal Year: 2005
    ..Using this intriguing source will require an extension of econometric models intended for use with "count" data...
  10. An Economic Study of Three Decades of Smoking Cessation
    Donald Kenkel; Fiscal Year: 2005
    ..Study 1 will also yield measures of consumer information that will be incorporated into Study 2's econometric models. Study 2 will provide econometric estimates of the effects of public policies on smoking cessation...
  11. Impact of Medicaid Prescription Copayments in Patients with Schizophrenia
    Jalpa Doshi; Fiscal Year: 2009
    ..We will estimate a series of econometric models to examine the impact of increases in copayment levels and increases in the brand/generic copay differential ..
  12. Mental Disorders, Private Insurance, and SSDI Benefits
    David Salkever; Fiscal Year: 2001
    This project will specify and estimate econometric models of transitions from private, long-term disability (LTD) benefits to Social Security Disability insurance (SSDI) benefits by employees who are on LTD as a result of a mental ..
  13. An Econometric Analysis of Cigarette Price Search and Tax Incidence
    Donald Kenkel; Fiscal Year: 2009
    ..Specific Aim 1 is to estimate econometric models of the impact of border crossing on the price paid for cigarettes...
  14. The Effect of Mexican Anti-Poverty Program on Stress
    LIA FERNALD; Fiscal Year: 2004
    ..development in relation to socioeconomic status (SES); and 4) to apply this knowledge of demographic and econometric models, and human development to the development of socio-economic metrics and analysis of health outcomes...
  15. A Performance Benchmarking Tool for Kidney Transplantation
    Constantia Petrou; Fiscal Year: 2007
    ..tool that will address gaps that exist in current hospital ranking systems using advanced statistical and econometric models that have never been applied in this space...
  16. Development of Econometric Models for Improved Estimation of Prevention Program B
    ROBERT EDWARD contact ROSENMAN; Fiscal Year: 2010
    ..Such knowledge is helpful to policy makers as they decide how to prioritize limited resources for social programs. ..
  17. Health and Air Quality Regulation in Delhi, India
    Naresh Kumar; Fiscal Year: 2006
    ..Spatial-statistical and econometric models will be employed to investigate interaction between air quality, economic choices and respiratory health ..
  18. CHILDREN AND FAMILIES: ECONOMICS
    James Heckman; Fiscal Year: 2001
    ..We also seek support to complete the task of constructing rigorously justified econometric models for analyzing life cycle dynamics that are more general than the standard grade transition models currently ..
  19. LATENT CLASS ANALYSIS OF DEMAND FOR MEDICAL CARE SERVICE
    PRAVIN TRIVEDI; Fiscal Year: 1999
    The objective of the research proposed here is to develop and evaluate alternative econometric models for the empirical analysis of the demand for medical care services...
  20. DTC Advertising Effect on Adherence to Statin Therapy
    W Bradford; Fiscal Year: 2006
    ..A series of econometric models will be estimated to determine the adherence and health effects of DTCA. [unreadable] [unreadable]
  21. Impact of Poor Health & AIDS on Small Businesses in SA
    Mark Pauly; Fiscal Year: 2003
    ..They will be useful for predicting the effect of changes in health on economic activity in this sector, and for allocating resources for disease prevention and treatment. ..
  22. Youth Alcohol, Tobacco and Marijuana Use: Effects of Hours of Work and Wages
    Robert Kaestner; Fiscal Year: 2009
    ..The proposed research will identify the importance of employment and earned income on youth substance use and produce information that can be used to design effective public health policy to address this problem. ..
  23. Welfare Reform, Fertility and Reproductive Behavior
    Robert Kaestner; Fiscal Year: 2003
    ....
  24. Long Term Cost and Outcomes of Breast Cancer Screening
    Paul Fishman; Fiscal Year: 2006
    ..The results of our study will help guide researchers and policy makers in planning and implementing brief interventions for a wide range of health behaviors. ..
  25. New Evidence on the Persistence of High Health Spending
    Richard Hirth; Fiscal Year: 2009
    ..We will provide an example of how such estimates can inform the evaluation of risk-adjustment and reinsurance as mechanisms to improve the functioning of small group health insurance markets. ..
  26. Costs of Occupational Injury and Illness
    J Leigh; Fiscal Year: 2009
    ..But reported national injury rates have been fallen since 1992. Moreover, Workers'Compensation costs fell from 1993 to 1998 but have risen since 1999. Current and comprehensive estimates are needed. ..
  27. Impact of Changing Public Policy on the Family
    Jonathan Gruber; Fiscal Year: 2005
    ..Wade. ..
  28. Behavioral factors and dietary change in WHTFSMP
    Alok Bhargava; Fiscal Year: 2003
    ..Overall, the results will facilitate the design of policies for improving health of especially minority women in the United States and will be useful for analyses of the Women's Health Initiative data. ..
  29. Assessing Medical Need Among Children in Managed Care
    Paul Fishman; Fiscal Year: 2003
    ..Pediatric risk assessment research has also not explored opportunities to use all information available in managed care information systems. ..
  30. PARENTAL EMPLOYMENT AND CHILD DEVELOPMENT
    CHRISTOPHER RUHM; Fiscal Year: 2002
    ..This project will also improve on earlier research by examining a wider set of child outcomes and considering the effects of paternal employment. ..
  31. The Health Insurance Dynamics of Older Americans
    MARY BUNDORF; Fiscal Year: 2004
    ..abstract_text> ..
  32. Effects of Health Plan Report Cards on Quality of Care
    MARY BUNDORF; Fiscal Year: 2004
    ..This information is essential for both large purchasers, such as the Medicare program and employers, and policy makers to determine the appropriate role of these types of interventions in improving quality of care. ..
  33. LABOR MARKET OUTCOMES OF LONG TERM CANCER SURVIVORS
    Cathy Bradley; Fiscal Year: 2004
    ....
  34. Harvard University Health Services Research Training Gr*
    Milton Weinstein; Fiscal Year: 2008
    ..This proposal will allow the next generation of these investigators to continue to address evolving issues in health services research. ..
  35. CLINICAL TRIALS AND OUTCOMES RESEARCH
    Daniel Heitjan; Fiscal Year: 2002
    ..It is anticipated, however, that the resulting methods will be applicable much more broadly. ..
  36. Dental Coverage Transistions, Utilization and Retirement
    RICHARD MANSKI; Fiscal Year: 2009
    ..Results obtained from this project will establish the independent effect of dental coverage on dental use and as a consequence provide important and timely information for policy makers. ..
  37. The Safety Net, Medicaid, and Child Health Outcomes
    Anthony Losasso; Fiscal Year: 2009
    ..A final area of study will examine how the relationship between the health care safety net and children's health outcomes differs by race and ethnicity. ..
  38. IS NON-ADHERENCE A REVEALED PREFERENCE
    Leslie Lenert; Fiscal Year: 2003
    ..We will also use an expert panel to assess the clinical match between patients' regimens and their preferences. ..
  39. Natural history of acute and chronic HCV in blood donors
    Michael Busch; Fiscal Year: 2008
    ..These investigations will yield important insights into HCV pathogenesis and clarify the natural history of disease for the large number of HCV infected persons identified through donor screening. ..
  40. Estrogen, Inflammation and Cardiovascular Risk
    David Reuben; Fiscal Year: 2003
    ..These findings may provide substantial insight into why CEE appears to promote early but protect against late cardiovascular effects. ..
  41. PRICE INDEXES OF MENTAL HEALTH TREATMENT
    Richard Frank; Fiscal Year: 2002
    ..To assess outcomes we will use clinical literature along with three expert panels of clinician-researchers to rate expected outcomes for specific combinations of consumers and treatments. ..
  42. Children with Chronic Health Conditions: Family Impact
    KAREN KUHLTAHU; Fiscal Year: 2002
    ....
  43. Away From Home and Out of School
    Deborah A Cohen; Fiscal Year: 2010
    ..The findings will be useful to inform future community and population level interventions to promote healthy eating, active living, and obesity control. ..
  44. NETWORK EFFECTS IN MENTAL HEALTH MANAGED CARE
    Thomas McGuire; Fiscal Year: 2002
    ..4) Test the behavior of the managed care plans against the predictions of the optimal network theory. ..
  45. MEDICAL OUTCOMES IN THE PRICING OF HOSPITAL PROCEDURES
    Avi Dor; Fiscal Year: 2001
    ..However, based on 1994 frequencies, final samples are expected to range from 900 to 2,400 per year, depending on the procedure and elective/emergency setting. ..
  46. Treatment of Fungal Infections with ATAK Cells
    Ashraf Ibrahim; Fiscal Year: 2004
    ..Furthermore, the genetic construct targeting ATAK cells to Candida can easily be adapted to any other pathogen against which a MAb has been raised. ..
  47. Optimal Strategies for Management of HIV Disease
    Kenneth Freedberg; Fiscal Year: 2008
    ..Freedberg will create a multiplicative effect in increasing research capability in this important area of HIV-related patient-oriented investigation. ..
  48. Impact of the Medicare Part D Benzodiazepine Exclusion on Managed Care Patients
    Susan Ettner; Fiscal Year: 2008
    ..Our findings will inform the ongoing debate over amending Part D legislation to include BZD coverage by providing objective data to guide policymakers on the likely costs and benefits. [unreadable] [unreadable] [unreadable]..
  49. Primate Model of the Transition to Cocaine Addiction
    JAMES ROWLETT; Fiscal Year: 2005
    ..The results will provide needed information for developing a nonhuman primate model that can serve as a quantitative platform for future research on neuroadaptations underlying the transition to persistent cocaine self-administration. ..
  50. Consumer Influences of Treatment of Depression
    Richard Kravitz; Fiscal Year: 2004
    ..e., should DTCA be further regulated?) while also contributing to our understanding of the social influences on diagnosis and treatment of depression in primary care settings. ..
  51. HMO Selection Incentives and Underprovision of MH Care
    Zhun Cao; Fiscal Year: 2006
    ..abstract_text> ..
  52. Economic Impacts of New Drugs
    Sharon Lise Normand; Fiscal Year: 2006
    ..Finally, we will examine the proposition that offsets occur differentially across racial and ethnic groups, for high utilizers and according to the organization of insurance arrangements. [unreadable] [unreadable]..
  53. A Genetic Screening Policy Model for Colorectal Cancer
    Scott Ramsey; Fiscal Year: 2006
    ..The model will incorporate QOL information from Aim 2, along with family history, clinical, and screening information from the Seattle CFR. ..
  54. Improving Safety Culture and Outcomes in Healthcare
    Laurence Baker; Fiscal Year: 2006
    ..abstract_text> ..
  55. The Economics of Mental Health Disparties
    Frederick Zimmerman; Fiscal Year: 2007
    ..Finally, the last 18 months of the grant will be devoted to developing a new research protocol on the role of time preference (i.e., impatience or delay of gratification) in determining patient demand for mental health services. ..
  56. Assisted Patient-Selection for Thrombolytics in Stroke
    David Kent; Fiscal Year: 2007
    ..unreadable] [unreadable]..
  57. Industry-Sponsored Research Contracts:..Phase II
    Michelle Mello; Fiscal Year: 2004
    ..abstract_text> ..
  58. MEDICAID MGD CARE FOR CHILDREN WITH SPEC HLTH CARE NEEDS
    JEAN MITCHELL; Fiscal Year: 2003
    ..abstract_text> ..
  59. Novel Antifungal Strategies for Lethal Mucormycosis
    Ashraf Ibrahim; Fiscal Year: 2007
    ..unreadable] [unreadable] [unreadable]..
  60. Resource and QOL Consequences of Lung Cancer Screening
    Margaret Byrne; Fiscal Year: 2007
    ..abstract_text> ..
  61. Macro-social & Parent Influence on Adolescents' Drug Use
    Matthew Farrelly; Fiscal Year: 2007
    ..Generalized Growth Mixture Modeling will be used to test the study hypotheses. ..
  62. Schools, Neighborhoods, and Adolescent Mental Health
    Michele Siegel; Fiscal Year: 2004
    ..It will also demonstrate a method for adjusting for the self-selection of adolescents into schools; most studies of school and neighborhood effects cannot correct for the resulting selection bias. ..
  63. Detecting Errors in Blood Labs Using Bayesian Networks
    Jason Doctor; Fiscal Year: 2008
    ..By reducing errors in the clinical laboratory, lives and [unreadable] substantial health-care resources will be saved. [unreadable] [unreadable] [unreadable] [unreadable]..